Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement
- PMID: 23987661
- PMCID: PMC3783929
- DOI: 10.1089/thy.2013.0496
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement
Comment on
-
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.Thyroid. 2013 Oct;23(10):1211-25. doi: 10.1089/thy.2012.0606. Epub 2013 Aug 3. Thyroid. 2013. PMID: 23692026 Review.
References
-
- Verburg FA. Luster M. Cupini C. Chiovato L. Duntas L. Elisei R. Feldt-Rasmussen U. Rimmele H. Seregni E. Smit JW. Theimer C. Giovanella L. Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement. Thyroid. 2013;23:1211–1225. - PubMed
-
- Spencer C. Petrovic I. Fatemi S. Current thyroglobulin autoantibody (TgAb) assays often fail to detect interfering TgAb that can result in the reporting of falsely low/undetectable serum Tg IMA values for patients with differentiated thyroid cancer. J Clin Endocrinol Metab. 2011;96:1283–1291. - PubMed
-
- Latrofa F. Ricci D. Montanelli L. Rocchi R. Piaggi P. Sisti E. Grasso L. Basolo F. Ugolini C. Pinchera A. Vitti P. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. J Clin Endocrinol Metab. 2012;97:3974–3982. - PubMed
-
- Spencer CA. Clinical review: clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC) J Clin Endocrinol Metab. 2011;96:3615–3627. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical